drugset / Trial / NCT00421044
A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Patients who participated in the core EPO2121 study and did not clinically progress may participate in this extension protocol to further evaluate the safety, tolerability, and efficacy of patupilone.
Timeline
- Start
- 2006-05
- Primary completion
- 2008-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Patupilone | Small molecule | — | — |